MAPK3 and acute lymphoblastic leukemia: Overall, our results suggest that intracellular Ca2+-related ERK1/2 signaling pathway attenuates dexamethasone sensitivity and apoptosis in ALL cells by decreasing Δψm collapse, ROS production, cytochrome c release from mitochondria, and caspase-3 activation.